KBIA’s Rebecca Smith has more on what they are and were designed to do, as well as how they impact the cost of medications at ...

For respondents facing novel Federal Trade Commission theories, the lesson is that early engagement—not reflexive litigation—can yield outcomes that address regulatory concerns while preserving ...

I am a 68-year-old male on a Medicare Advantage plan through my last employer. How does the new TrumpRx plan fit into Medicare? Currently, Express Scripts manages my ...

Launched this month, TrumpRx.gov aims to provide prices for many popular medicines similar to the lowest paid by other developed nations.

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

It seems that every parenting expert on the internet has a “script” for what to say when your child is having a tantrum or meltdown. Do they actually work?

The MarketWatch News Department was not involved in the creation of this content. Settlement resolves FTC lawsuit alleging that Express Scripts' conduct resulted in artificially inflated insulin drug ...

WASHINGTON – The Federal Trade Commission (FTC) has secured a landmark settlement with one of the nation’s largest pharmacy benefit managers (PBMs), Express Scripts, Inc., and its affiliated entities ...

The Federal Trade Commission has announced what it called a "landmark settlement" with Express Scripts over insulin pricing. The settlement resolves a lawsuit alleging that Express Scripts' conduct ...

The FTC first sued Express Scripts, CVS Caremark, and Optum in 2024, claiming anticompetitive and unfair rebating practices surrounding insulin. “Caremark, [Express Scripts], and Optum—as medication ...

The Federal Trade Commission has agreed to what it called a “landmark” settlement with Express Scripts, allowing the company to bow out of the agency’s lawsuit against major pharmacy benefit managers ...

Express Scripts, a pharmacy benefit manager and subsidiary of Cigna (CI), has reached a settlement with the FTC over accusations that it artificially inflated the prices of insulin drugs, violating ...